Catherine Moukheibir

MLTX

Catherine Moukheibir serves as Director at MoonLake Immunotherapeutics (MLTX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$1.66M

Net Position

Net Seller

$1.66M

Companies Traded

MLTX, IRWD

Active Period

Jun 2024 – Jul 2025

2 total trades

Most Recent

Sell MLTX

Jul 3, 2025 · $1.15M

Catherine Moukheibir's Insider Trading at MoonLake Immunotherapeutics (MLTX)

Buys

0 · $0.00

Sells

1 · $1.15M

Total Shares Bought

Total Shares Sold

23,500

MLTX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 3, 2025↗	Sell	23,500	$48.79	$1.15M	0

Catherine Moukheibir's Insider Trading at Ironwood Pharmaceuticals, Inc. (IRWD)

Buys

0 · $0.00

Sells

1 · $517.7K

Total Shares Bought

Total Shares Sold

80,000

IRWD Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 10, 2024↗	Sell	80,000	$6.47	$517.7K	84,207

Related Insiders

Gregory S. Martini

officer: Chief Financial Officer

IRWDSell · Feb 24, 2026

Ronald Silver

officer: Principal Accounting Officer

IRWDSell · Feb 24, 2026

Michael Shetzline

officer: SVP, CMO, Head-Res&Drug

IRWDSell · Feb 24, 2026

Tammi L Gaskins

officer: Chief Commercial Officer

IRWDSell · Feb 24, 2026

Thomas A MCCOURT

director, officer: Chief Executive Officer

IRWDSell · Feb 24, 2026

Minardo John

officer: Chief Legal Officer

IRWDSell · Feb 24, 2026

Ronald Silver

Principal Accounting Officer

IRWDSell · Jan 5, 2026

Matthias Bodenstedt

Chief Financial Officer

MLTXSell · Dec 19, 2025

Explore More Insider Trading Data

MLTX Insider Trading Activity

View all insider trades at MoonLake Immunotherapeutics

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity